OA11506A - Aryl fused azapolycyclic compounds. - Google Patents

Aryl fused azapolycyclic compounds. Download PDF

Info

Publication number
OA11506A
OA11506A OA1200000295A OA1200000295A OA11506A OA 11506 A OA11506 A OA 11506A OA 1200000295 A OA1200000295 A OA 1200000295A OA 1200000295 A OA1200000295 A OA 1200000295A OA 11506 A OA11506 A OA 11506A
Authority
OA
OAPI
Prior art keywords
aza
triene
trideca
tetraene
hexadeca
Prior art date
Application number
OA1200000295A
Other languages
English (en)
Inventor
Jotham Wadsworth Coe
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA11506A publication Critical patent/OA11506A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
OA1200000295A 1998-04-29 2000-10-25 Aryl fused azapolycyclic compounds. OA11506A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8355698P 1998-04-29 1998-04-29

Publications (1)

Publication Number Publication Date
OA11506A true OA11506A (en) 2004-05-14

Family

ID=22179102

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200000295A OA11506A (en) 1998-04-29 2000-10-25 Aryl fused azapolycyclic compounds.

Country Status (42)

Country Link
US (3) US6462035B1 (no)
EP (1) EP1076650B1 (no)
JP (1) JP2002513007A (no)
KR (1) KR100420423B1 (no)
CN (1) CN1144787C (no)
AP (1) AP1154A (no)
AR (1) AR018596A1 (no)
AT (1) ATE258921T1 (no)
AU (1) AU749831B2 (no)
BG (1) BG64556B1 (no)
BR (1) BR9910058A (no)
CA (1) CA2330576A1 (no)
CO (1) CO5021124A1 (no)
DE (1) DE69914594T2 (no)
DK (1) DK1076650T3 (no)
DZ (1) DZ2778A1 (no)
EA (1) EA003669B1 (no)
ES (1) ES2213354T3 (no)
GT (1) GT199900059A (no)
HK (1) HK1036453A1 (no)
HR (1) HRP20000731A2 (no)
HU (1) HUP0103340A3 (no)
ID (1) ID26700A (no)
IL (1) IL138917A0 (no)
IS (1) IS5649A (no)
MA (1) MA26623A1 (no)
MY (1) MY133474A (no)
NO (1) NO317300B1 (no)
NZ (1) NZ507035A (no)
OA (1) OA11506A (no)
PA (1) PA8471301A1 (no)
PE (1) PE20000435A1 (no)
PL (1) PL344010A1 (no)
PT (1) PT1076650E (no)
SK (1) SK15952000A3 (no)
TN (1) TNSN99080A1 (no)
TR (1) TR200003122T2 (no)
UA (1) UA61991C2 (no)
UY (1) UY25636A1 (no)
WO (1) WO1999055680A1 (no)
YU (1) YU64400A (no)
ZA (1) ZA992971B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK286886B6 (sk) 1997-12-31 2009-07-06 Pfizer Products Inc. Azapolycyklické zlúčeniny s anelovanou arylskupinou, ich použitie, farmaceutické kompozície na ich báze a medziprodukty
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
CZ20032814A3 (cs) * 2001-04-20 2004-08-18 Pfizeráproductsáinc Způsob přípravy �Ź@@substituovaných indenů a aryl@kondezovaných azapolycyklických sloučenin
PL370549A1 (en) * 2001-10-31 2005-05-30 Pfizer Products Inc. Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
EP1451202B1 (en) 2001-11-30 2008-08-20 Pfizer Products Inc. Aryl fused azapolycyclic compounds
AU2003233228A1 (en) * 2002-05-03 2003-11-17 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolyl-cis/trans-isomerases
US20040224963A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US20040224962A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
BRPI0412712A (pt) * 2003-07-21 2006-09-26 Pfizer Prod Inc compostos azapolicìclicos fundidos com heteroarila
CA2533100A1 (en) * 2003-07-21 2005-01-27 Pfizer Products Inc. Aryl fused azapolycyclic compounds
US20050043407A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
US20090093512A1 (en) * 2004-12-07 2009-04-09 Pfizer Inc 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta[a]inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulating cholinergic function and in the treatment of addictive disorders
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
DE102005061426A1 (de) * 2005-12-22 2007-07-05 Grünenthal GmbH Substituierte tricyclische Piperidon-Derivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687937A (en) * 1970-06-23 1972-08-29 Us Of America The 1,5-methano-3-benzazocine derivatives
JPS4914473A (no) * 1972-06-09 1974-02-07
JPS4924968A (no) * 1972-07-01 1974-03-05

Also Published As

Publication number Publication date
BG104983A (en) 2001-09-28
ATE258921T1 (de) 2004-02-15
IS5649A (is) 2000-09-29
DK1076650T3 (da) 2004-05-24
ID26700A (id) 2001-02-01
TR200003122T2 (tr) 2001-03-21
ZA992971B (en) 2000-10-30
CN1144787C (zh) 2004-04-07
BG64556B1 (bg) 2005-07-29
DE69914594T2 (de) 2004-12-09
HRP20000731A2 (en) 2001-06-30
MA26623A1 (fr) 2004-12-20
CA2330576A1 (en) 1999-11-04
AP1154A (en) 2003-03-27
DZ2778A1 (fr) 2005-04-23
TNSN99080A1 (fr) 2005-11-10
SK15952000A3 (sk) 2002-06-04
YU64400A (sh) 2003-01-31
UY25636A1 (es) 2000-02-23
NO317300B1 (no) 2004-10-04
NO20005397D0 (no) 2000-10-26
US6706702B2 (en) 2004-03-16
HK1036453A1 (en) 2002-01-04
AR018596A1 (es) 2001-11-28
ES2213354T3 (es) 2004-08-16
AP9901524A0 (en) 1999-06-30
PA8471301A1 (es) 2000-09-29
PL344010A1 (en) 2001-09-24
NZ507035A (en) 2003-05-30
JP2002513007A (ja) 2002-05-08
EP1076650B1 (en) 2004-02-04
US7122534B2 (en) 2006-10-17
NO20005397L (no) 2000-10-26
MY133474A (en) 2007-11-30
AU2951699A (en) 1999-11-16
HUP0103340A2 (hu) 2002-02-28
UA61991C2 (en) 2003-12-15
HUP0103340A3 (en) 2002-10-28
PE20000435A1 (es) 2000-05-26
US20030008890A1 (en) 2003-01-09
WO1999055680A1 (en) 1999-11-04
EA003669B1 (ru) 2003-08-28
US20040167149A1 (en) 2004-08-26
KR100420423B1 (ko) 2004-03-04
EP1076650A1 (en) 2001-02-21
BR9910058A (pt) 2000-12-26
GT199900059A (es) 2000-10-11
CO5021124A1 (es) 2001-03-27
IL138917A0 (en) 2001-11-25
PT1076650E (pt) 2004-05-31
US6462035B1 (en) 2002-10-08
KR20010043143A (ko) 2001-05-25
EA200000996A1 (ru) 2001-06-25
CN1298394A (zh) 2001-06-06
DE69914594D1 (de) 2004-03-11
AU749831B2 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
US20030130261A1 (en) Aryl fused azapolycyclic compounds
OA11506A (en) Aryl fused azapolycyclic compounds.
AP1170A (en) Aryl fused azapolycyclic compounds.
US7186870B2 (en) Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
JP4386639B2 (ja) セロトニンアゴニストおよびアンタゴニストとしての置換されたピロロキノリン化合物およびピリドキノリン化合物
AU2002234836A1 (en) Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
Philippe et al. Highly stereoselective Friedel–Crafts type cyclization. Facile access to enantiopure 1, 4-dihydro-4-phenyl isoquinolinones
JPH04234845A (ja) 新規コリンエステラーゼ阻害剤としての三環式環状アミン
MXPA00010540A (en) Aryl fused azapolycyclic compounds
Ong et al. Synthesis and analgesic activity of some spiro [dibenz [b, f] oxepin-10, 4'-piperidine] derivatives
CZ20003972A3 (cs) Aryl-arelované azapolycyklické sloučeniny
DiMaio et al. A new efficient synthesis of the 16-epimers of (±)-3-hydroxy-16, 17-butanomorphinan
FEVIG et al. Patent 2432181 Summary